Early Access — free while we kick the tires
EdgarHawk

Serge Saxonov

Chief Executive Officer

Director Officer

Latest: 10x Genomics, Inc. CEO selling · June 2026

1 filing analyzed · 1 company · Latest 2026-06-24

Never miss a filing from Serge Saxonov

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
10x Genomics, Inc. TXG 0 1 Net selling

Activity

June 2026
2026-06-24 10x Genomics, Inc. TXG 10b5-1 Plan
medium
Sell
30,000 shares
$1,033,269
Significance 4/10

TXG CEO Serge Saxonov sells 30,000 shares for $1.0M via 10b5-1 plan; holds 1.11M post-sale.

Serge Saxonov executed four separate sales totaling 30,000 shares for $1,033,268.62 on 2026-06-22 under a pre-arranged 10b5-1 trading plan adopted 2025-11-29, reducing his holdings by 2.6% to 1,108,380 shares. The company reported negative net income of $-13,470,000.00 in the latest quarter and operated unprofitably over its most recent full fiscal year, though revenue grew 5.2% year-over-year. His same-ticker sales history shows mixed outcomes: a May 2026 sale generated a +42.2% 30-day return, while a July 2023 sale produced a -23.9% 30-day return. As a scheduled 10b5-1 transaction, this sale is divorced from discretionary timing and does not reflect a judgment call by the executive.

Related insiders